Sclerosis: all 3,103 studies
Page 31 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT00206635
- Study of the Effects Strengthening Exercises in Individuals With ALSCompletedNCT00204464Phase 2
- Safety and Efficacy Study of Copaxone Administered in Combination With MinocyclineCompletedNCT00203112Phase 2
- Safety and Efficacy Study of Copaxone Administered in Combination With N-AcetylcysteineCompletedNCT00203099Phase 2
- A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple SclerosisCompletedNCT00203086
- A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.CompletedNCT00203073Phase 2
- Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMSTerminatedNCT00202995Phase 4
- A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved DoseCompletedNCT00202982Phase 2
- Use of Cannabinoids in Patients With Multiple SclerosisStatus unknownNCT00202423Phase 2
- Efficacy of Anti-Tubercular Vaccination in Multiple SclerosisCompletedNCT00202410Phase 2/3
- Gene Expression in MS Patients Before and During Treatment With Interferon-betaTerminatedNCT00202384
- Multiple Sclerosis Rehabilitation StudyCompletedNCT00202254Not applicable
- Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple SclerosisCompletedNCT00200655Phase 3
- Efficacy of 3,4-DAP in Fatigue Associated With Multiple SclerosisCompletedNCT00190268Phase 3
- Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MSCompletedNCT00168766Phase 4
- Efficacy and Safety of BG00012 in MSCompletedNCT00168701Phase 2
- Improving New Learning and Memory in Multiple SclerosisCompletedNCT00166283Not applicable
- The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral SclerosisTerminatedNCT00160004Phase 1/2
- Amyotrophic Lateral Sclerosis and Frontotemporal DementiaTerminatedNCT00159198
- Restoration of Walking in Multiple Sclerosis Using Treadmill Training.CompletedNCT00156676Not applicable
- Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS PatientsStatus unknownNCT00151801Phase 2
- The Efficacy and Safety of Escitalopram for Depression in Multiple SclerosisTerminatedNCT00151294Phase 4
- Study Evaluating Mitoxantrone in Multiple SclerosisTerminatedNCT00146159Phase 3
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple SclerosisCompletedNCT00146068Phase 4
- Modafinil in Multiple SclerosisCompletedNCT00142402Not applicable
- Phase II Study Using Thalidomide for the Treatment of ALSCompletedNCT00140452Phase 2
- R(+) Pramipexole in Early Amyotrophic Lateral SclerosisCompletedNCT00140218Phase 1/2
- A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple SclerosisCompletedNCT00139789Phase 3
- Sleep Disorders in Patients With Multiple SclerosisStatus unknownNCT00137904
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple SclerosisCompletedNCT00137176Not applicable
- Trial of Sodium Valproate in Amyotrophic Lateral SclerosisCompletedNCT00136110Phase 3
- POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple SclerosisStatus unknownNCT00127075Phase 3
- Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00125203Phase 2/3
- Health Behavior Change in Chronic Disease ManagementCompletedNCT00118547Not applicable
- AVONEX® Combination Trial - "ACT"CompletedNCT00112034Phase 4
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple SclerosisCompletedNCT00109161Phase 2
- Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)CompletedNCT00107770Phase 1/2
- A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.WithdrawnNCT00104143Phase 2
- Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple SclerosisCompletedNCT00103974Phase 1
- Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) SubjectsWithdrawnNCT00101959Phase 4
- BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsCompletedNCT00099502Phase 3
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple SclerosisCompletedNCT00099307
- Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT00097760Phase 2
- Three Months Treatment With SB683699 In Patients With Relapsing Multiple SclerosisCompletedNCT00097331Phase 2
- A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple SclerosisCompletedNCT00097188Phase 2
- Treating Multiple Sclerosis With Sirolimus, an Immune System SuppressorTerminatedNCT00095329Phase 1/2
- The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis PatientsCompletedNCT00094068
- Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)CompletedNCT00086671Phase 2
- Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)CompletedNCT00079495Phase 2
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaCompletedNCT00077584Phase 3
- Safety of RG2077 in Patients With Multiple SclerosisCompletedNCT00076934Phase 1
- Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00072709Phase 2
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple SclerosisCompletedNCT00071838Phase 2
- Brain Function in Primary Lateral SclerosisCompletedNCT00071435
- Creatine for the Treatment of Amyotrophic Lateral SclerosisCompletedNCT00070993Phase 2
- Study of Creatine Monohydrate in Patients With Amyotrophic Lateral SclerosisStatus unknownNCT00069186Phase 3
- Treatment of Multiple Sclerosis Using Over the Counter InosineCompletedNCT00067327Phase 2
- MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple SclerosisCompletedNCT00064909
- Improving Memory in Patients With Multiple SclerosisWithdrawnNCT00062972Phase 3
- Stem Cell Transplant to Treat Patients With Systemic SclerosisCompletedNCT00058578Phase 1
- Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis PatientsCompletedNCT00050232Phase 3
- Minocycline to Treat Amyotrophic Lateral SclerosisCompletedNCT00047723Phase 3
- Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.CompletedNCT00047580Phase 3
- Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic SclerosisCompletedNCT00043706Phase 1/2
- Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple SclerosisCompletedNCT00043264Phase 2
- Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma PatientsTerminatedNCT00040651Phase 1
- High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisCompletedNCT00040482Phase 2
- Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
- Auditory Function in Patients With and Without Multiple SclerosisCompletedNCT00037947Phase 2
- Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
- Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple SclerosisCompletedNCT00037102Phase 4
- A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral SclerosisCompletedNCT00036413Phase 2
- A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple SclerosisTerminatedNCT00035529Phase 2
- Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisCompletedNCT00030966Phase 3
- Safety and Efficacy of Natalizumab in the Treatment of Multiple SclerosisCompletedNCT00027300Phase 3
- Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral SclerosisCompletedNCT00023075
- Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALSCompletedNCT00021697Phase 3
- Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisCompletedNCT00017628Phase 1
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- Screening and Natural History: Primary Lateral Sclerosis and Related DisordersCompletedNCT00015444
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Rolipram to Treat Multiple SclerosisCompletedNCT00011375Phase 2
- Yoga: Effect on Attention in Aging & Multiple SclerosisCompletedNCT00010998Phase 2
- Natural Antioxidants in the Treatment of Multiple SclerosisCompletedNCT00010842Phase 1/2
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersCompletedNCT00010335Phase 1
- Amyotrophic Lateral Sclerosis (ALS) Gulf War StudyCompletedNCT00007722
- Psychological Treatments for SclerodermaCompletedNCT00007267Phase 2
- Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisStatus unknownNCT00006393
- Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple SclerosisStatus unknownNCT00006060
- Clinical Trial of Creatine in Amyotrophic Lateral SclerosisCompletedNCT00005766Phase 2
- Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00005674Phase 2
- A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple SclerosisCompletedNCT00004816Phase 1
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisCompletedNCT00004814Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
- Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron DiseaseCompletedNCT00004771Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple SclerosisCompletedNCT00004744Phase 3
- Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneStatus unknownNCT00004645Phase 3
- Determinants of Disease Severity in Amyotrophic Lateral SclerosisStatus unknownNCT00004457
- Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2
- Zenapax to Treat Multiple SclerosisCompletedNCT00001934Phase 2